WeVote

Bill

Bill

SB 460

Public Health - As introduced, adds the legislative librarian as a party to which the department of health must submit an annual report based on data received by a county or district health department that operates a needle and hypodermic syringe exchange program, including the number of people served, number of needles, syringes, and supplies dispensed and returned to the program, number of naloxone kits distributed, and the number and type of treatment referrals provided. - Amends TCA Title 4; Title 8; Title 14; Title 29; Title 33; Title 37; Title 39; Title 53; Title 56; Title 63; Title 68 and Title 71.

114th Regular Session (2025-2026) Introduced by Richard Briggs

Tennessee requires health department annual reporting to legislature on needle exchange program metrics including participants served, supplies dispensed, naloxone distribution, and treatment referrals.

Passed on Second Consideration, refer to Senate Commerce and Labor Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 460

Legislative bill overview

SB 460 requires Tennessee's Department of Health to submit annual reports to the legislative librarian containing detailed data from county and district needle exchange programs, including metrics on people served, supplies distributed/returned, naloxone kits dispensed, and treatment referrals provided. The bill amends multiple sections of Tennessee law related to public health administration and record-keeping.

Why is this important

Needle exchange programs are evidence-based public health interventions that reduce disease transmission (HIV, hepatitis C) and connect people to treatment services. Creating mandatory legislative reporting establishes transparency and accountability for these programs, allowing lawmakers to assess effectiveness and resource allocation. This data can inform future public health policy decisions and funding priorities.

Potential points of contention

  • Program legitimacy debate: Some lawmakers and constituents view needle exchanges as enabling drug use rather than harm reduction, potentially viewing mandatory reporting as legitimizing controversial programs
  • Privacy and data security concerns: Collecting and reporting detailed program data raises questions about participant privacy protections and potential misuse of identifying information
  • Implementation burden: County and district health departments must develop new data collection systems and reporting procedures, creating administrative costs and compliance challenges
  • Treatment referral tracking: Measuring "number and type of treatment referrals" may be difficult to standardize across different health jurisdictions and raises questions about what constitutes a valid referral

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.